$149.23
0.86% today
NYSE, Apr 01, 07:45 pm CET
ISIN
US1598641074
Symbol
CRL

Charles River Laboratories International, Inc. Stock price

$150.52
-14.79 8.95% 1M
-46.45 23.58% 6M
-34.08 18.46% YTD
-118.21 43.99% 1Y
-133.45 46.99% 3Y
+24.31 19.26% 5Y
+71.23 89.83% 10Y
NYSE, Closing price Mon, Mar 31 2025
-5.03 3.23%
ISIN
US1598641074
Symbol
CRL
Sector
Industry

Key metrics

Market capitalization $7.70b
Enterprise Value $10.32b
P/E (TTM) P/E ratio 586.82
EV/FCF (TTM) EV/FCF 20.58
EV/Sales (TTM) EV/Sales 2.55
P/S ratio (TTM) P/S ratio 1.90
P/B ratio (TTM) P/B ratio 2.22
Revenue growth (TTM) Revenue growth -1.92%
Revenue (TTM) Revenue $4.05b
EBIT (operating result TTM) EBIT $559.35m
Free Cash Flow (TTM) Free Cash Flow $501.61m
Cash position $204.14m
EPS (TTM) EPS $0.26
P/E forward 32.42
P/S forward 2.01
EV/Sales forward 2.69
Short interest 8.37%
Show more

Is Charles River Laboratories International, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,804 stocks worldwide.

Charles River Laboratories International, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

20 Analysts have issued a Charles River Laboratories International, Inc. forecast:

3x Buy
15%
16x Hold
80%
1x Sell
5%

Analyst Opinions

20 Analysts have issued a Charles River Laboratories International, Inc. forecast:

Buy
15%
Hold
80%
Sell
5%

Financial data from Charles River Laboratories International, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
4,050 4,050
2% 2%
100%
- Direct Costs 2,781 2,781
1% 1%
69%
1,269 1,269
8% 8%
31%
- Selling and Administrative Expenses 348 348
17% 17%
9%
- Research and Development Expense - -
-
-
921 921
5% 5%
23%
- Depreciation and Amortization 362 362
15% 15%
9%
EBIT (Operating Income) EBIT 559 559
14% 14%
14%
Net Profit 16 16
97% 97%
0%

In millions USD.

Don't miss a Thing! We will send you all news about Charles River Laboratories International, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Charles River Laboratories International, Inc. Stock News

Neutral
Business Wire
7 days ago
WILMINGTON, Mass. & CAMBRIDGE, Mass.--(BUSINESS WIRE)---- $CRL #LIFEatCRL--Charles River and Valo Health announce the identification of an advanceable product candidate for treatment of lupus and other autoimmune diseases.
Neutral
Business Wire
21 days ago
WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories to Present at Barclays Global Healthcare Conference.
Neutral
Business Wire
28 days ago
PORTO, Portugal & SAN FRANCISCO--(BUSINESS WIRE)--FairJourney Biologics S.A., leaders in the discovery and optimization of antibodies, today announced that it had completed the acquisition of the South San Francisco site from Charles River Laboratories International, Inc. The acquisition aligns with FairJourney's ongoing strategic growth plan, and will significantly bolster the Company's antibo...
More Charles River Laboratories International, Inc. News

Company Profile

Charles River Laboratories International, Inc. is an early-stage contract research company, which provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and academic institutions. It operates through the following segments: Research Models & Services, Discovery & Safety Assessment and Manufacturing Support. The Research Models & Services segment comprises of the production and sale of research models, and also offers services designed to support its client's use of research models in screening non-clinical drug candidates. The Discovery & Safety Assessment segment offers discovery and safety assessment services, both regulated and non-regulated, in which it include both in vivo and in vitro studies, supporting laboratory services, and strategic preclinical consulting and program management to support product development. The Manufacturing Support segment provides endotoxin and microbial detection, avian vaccine and biologics testing solutions. The company was founded by Henry L. Foster in 1947 and is headquartered in Wilmington, MA.

Head office United States
CEO James Foster
Employees 20,100
Founded 1947
Website www.criver.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today